Edelfosine is primarily used in the field of cancer research and treatment. It is known for its ability to target and disrupt cancer cell membranes, leading to cell death via apoptosis. This makes it a potential candidate for chemotherapy, particularly in the treatment of certain types of leukemia, skin cancers, and other malignancies. Additionally, Edelfosine has been studied for its anti-inflammatory properties, which could be beneficial in managing autoimmune diseases. Its mechanism of action involves interfering with lipid metabolism in cell membranes, which can also make it useful in studying cellular processes and signaling pathways. It may also stimulate the immune system to fight abnormal cells. Researchers continue to explore its potential in combination therapies to enhance its efficacy and reduce side effects.